4.8 Article

Macrophage-Targeted Lipid Nanoparticle Delivery of microRNA-146a to Mitigate Hemorrhagic Shock-Induced Acute Respiratory Distress Syndrome

Journal

ACS NANO
Volume -, Issue -, Pages -

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsnano.3c01814

Keywords

Mannosylated lipid nanoparticle; acute respiratory distresssyndrome; inflammation; microRNA; alveolarmacrophages

Ask authors/readers for more resources

Alveolar macrophages respond to injurious physical forces during mechanical ventilation by inducing inflammation, which is regulated by the anti-inflammatory microRNA, miR-146a. Increasing miR-146a expression to supraphysiologic levels using untargeted lipid nanoparticles reduces ventilator-induced lung injury but requires a high initial dose of miR-146a, limiting its clinical applicability. This study developed mannosylated lipid nanoparticles that effectively mitigate lung injury at the initiation of mechanical ventilation with lower doses of miR-146a.
The pro-inflammatory response of alveolar macrophagesto injuriousphysical forces during mechanical ventilation is regulated by theanti-inflammatory microRNA, miR-146a. Increasing miR-146a expressionto supraphysiologic levels using untargeted lipid nanoparticles reducesventilator-induced lung injury but requires a high initial dose ofmiR-146a making it less clinically applicable. In this study, we developedmannosylated lipid nanoparticles that can effectively mitigate lunginjury at the initiation of mechanical ventilation with lower dosesof miR-146a. We used a physiologically relevant humanized in vitro coculture system to evaluate the cell-specifictargeting efficiency of the mannosylated lipid nanoparticle. We discoveredthat mannosylated lipid nanoparticles preferentially deliver miR-146ato alveolar macrophages and reduce force-induced inflammation in vitro. Our in vivo study using a clinicallyrelevant mouse model of hemorrhagic shock-induced acute respiratorydistress syndrome demonstrated that delivery of a low dose of miR-146a(0.1 nmol) using mannosylated lipid nanoparticles dramatically increasesmiR-146a levels in mouse alveolar macrophages and decreases lung inflammation.These data suggest that mannosylated lipid nanoparticles may havethe therapeutic potential to mitigate lung injury during mechanicalventilation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available